ST-segment elevation myocardial infarction (STEMI)

Latest STEMI content in interventional cardiology - research, practice, and education

Treating STEMI brings into play a series of clinical and organisational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

412 results

Intravascular lithotripsy or mechanical debulking in complex calcified coronary arteries: multicenter, prospective ROLLING STONE study

19 Mar 2026

The ROLLING STONE registry compares intravascular lithotripsy (IVL) and atherectomy (rotational and orbital) for treating heavily calcified coronary arteries, assessing real-world safety and effectiveness in percutaneous coronary interventions (PCI).

Reviewer

Aaysha Cader
Intravascular lithotripsy or mechanical debulking in complex calcified coronary arteries: multicenter, prospective ROLLING STONE study

Aspirin discontinuation timing with ticagrelor monotherapy in ACS: a post hoc analysis from TICO and T-PASS

11 Mar 2026

The TICO1 and T-PASS2 trials evaluated abbreviated DAPT followed by ticagrelor monotherapy compared to DAPT in patients with ACS undergoing PCI. Both trials demonstrated the safety and efficacy of abbreviated DAPT however, the optimal timing of aspirin discontinuation remains uncertain. This post hoc analysis compares the...

Nicola Ryan

Reviewer

Nicola Ryan
Optimal timing of aspirin discontinuation with ticagrelor monotherapy in ACS: insights from TICO and T-PASS

PCRonline @ ACC.26 Scientific Sessions

12 Mar 2026

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2026 Scientific Sessions #ACC26

PCRonline @ ACC.26 Scientific Sessions

Ticagrelor vs prasugrel in patients with diabetes and multivessel coronary artery disease: the TUXEDO-2 randomised clinical trial

17 Feb 2026

The TUXEDO-2 trial sought to directly compare prasugrel versus ticagrelor in diabetic patients undergoing percutaneous coronary intervention (PCI), with the aim of clarifying whether the non-inferiority of ticagrelor could be established.

Raffaele Piccolo

Reviewer

Raffaele Piccolo
TUXEDO-2 ticagrelor vs prasugrel in patients with diabetes and MVD CAD

Impact of complete revascularisation in relation to left ventricular function in patients with ST-segment elevation myocardial infarction and multivessel disease: a post hoc analysis of the COMPLETE randomised trial

05 Feb 2026

This study represents a prespecified subgroup analysis of the COMPLETE randomised trial, a large, international, randomised controlled study comparing a strategy of complete revascularisation with culprit-only percutaneous coronary intervention (PCI) in patients presenting with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD).

The present...

Murat Gökalp

Reviewer

Murat Gökalp

Reviewer

Ali Nazmi Calik
LV function after complete revascularisation in STEMI and MVD insights from the COMPLETE trial

Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

07 Jan 2026

The present analysis compared major adverse cardiac events in patients with significant coronary stenosis (FFR ≤ 0.80 or visual stenosis ≥ 90 %) versus those with non-significant stenosis (FFR > 0.80).

Ruxandra Sava

Reviewer

Ruxandra Sava
Alessandro Sticchi

Reviewer

Alessandro Sticchi
Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

Complex coronary complications

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses complex coronary complications through a series of challenging cases including dextrocardia with acute STEMI, fragile coronary anatomy risks, left main complications, and stent-related issues. It provides critical insights into recognizing and managing unexpected procedural challenges to improve patient safety.

Complication session

Coronary Pot Pourri - 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session presents a diverse range of complex coronary interventions, highlighting advanced techniques and strategies. Topics include the use of ECMO support for high-risk PCI and TAVI in cardiogenic shock, innovative approaches in left main interventions, challenging stent optimisation, and management of patients with combined severe...

Coronary Pot Pourri - 2

Challenging STEMI scenarios - Part 1

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses challenging STEMI scenarios with a focus on atypical presentations, complex complications, and advanced management strategies. Through diverse case discussions, it highlights approaches to overcome procedural difficulties, manage large thrombus burdens, and avoid clinical pitfalls in acute STEMI care.

Challenging STEMI scenarios - Part 1

Challenging STEMI scenarios - Part 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session presents complex STEMI cases that highlight the challenges of acute coronary syndrome management, including difficult arterial access, balancing reperfusion with embolization risks, and rare complications such as spontaneous coronary artery dissections. It emphasizes nuanced decision-making in high-stakes clinical scenarios.

Challenging STEMI scenarios - Part 2